Clinical Trials Browser

OTHER × Losartan × 90 days × Clear all

NCT05365893 2026-05-22

PHL Treatment in Pancreatic Cancer

Phase EARLY_PHASE1 Active not recruiting

Gastrointestinal

Pancreatic Ductal Adenocarcinoma

NCT04106856 2026-05-12

SHAPER

Phase 1 Active not recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT07265739 2026-05-06

Losartan and Paclitaxel in Platinum Resistant Ovarian Cancer

Phase 2 Not yet recruiting

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT05637216 2026-04-24

Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients

Phase 2 Recruiting

Radiation Fibrosis Syndrome, Breast Neoplasms, Camurati-Engelmann Syndrome, Fibrosis, Inflammation

NCT05077800 2026-04-13

FOLFIRINOX + Elraglusib + Losartan In Pancreatic Cancer

Phase 2 Active not recruiting

Gastrointestinal

Pancreatic Adenocarcinoma

NCT05607017 2026-04-06

Losartan in Prevention of Radiation-Induced Heart Failure

Phase EARLY_PHASE1 Completed

Radiation Fibrosis Syndrome, Breast Neoplasms

NCT06211335 2026-03-12

Losartan, Pembrolizumab and Stereotactic Body Radiation Therapy for the Treatment of Patients With Locally Recurrent, Refractory or Oligometastatic Head and Neck Squamous Cell Carcinoma

Phase 1 Recruiting

Squamous Cell Carcinoma of Head and Neck